Neuronetics (STIM) Return on Capital Employed (2018 - 2026)
Neuronetics (STIM) reported Return on Capital Employed of 27.96% for Q1 2026, up 525.0% year-over-year from 4.47% in Q1 2025, and little changed quarter-over-quarter from 27.82% in Q4 2025.
Neuronetics (STIM) Return on Capital Employed (2018 - 2026) Analysis & Trends
Neuronetics (STIM) has 9 years of Return on Capital Employed data on file, last reported at 27.96% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 27.96%, up 525.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 27.96% (up 525.0% YoY), and the FY2025 annual result was 28.4%, up 720.0% from the prior year.
- Return on Capital Employed steadied at 27.96% in Q1 2026 per STIM's latest filing, from 27.82% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 25.16% in Q1 2022 and troughed at 45.34% in Q4 2024.
- A 5-year average of 35.18% and a median of 35.74% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed tumbled 1958 bps in 2022, then jumped 1751 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 41.38% in 2022, then advanced by 13 bps to 36.12% in 2023, then fell by 26 bps to 45.34% in 2024, then jumped by 39 bps to 27.82% in 2025, then dropped by 0 bps to 27.96% in 2026.
- Business Quant data shows STIM's Return on Capital Employed at 27.96% in Q1 2026, 27.82% in Q4 2025, and 34.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | -27.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.96% |
| Dec 31, 2025 | -27.82% |
| Sep 30, 2025 | -34.08% |
| Jun 30, 2025 | -34.63% |
| Mar 31, 2025 | -33.21% |
| Dec 31, 2024 | -45.34% |
| Sep 30, 2024 | -40.14% |
| Jun 30, 2024 | -40.34% |
| Mar 31, 2024 | -28.86% |
| Dec 31, 2023 | -36.12% |
| Sep 30, 2023 | -41.61% |
| Jun 30, 2023 | -37.30% |
| Mar 31, 2023 | -36.68% |
| Dec 31, 2022 | -41.38% |
| Sep 30, 2022 | -35.74% |
| Jun 30, 2022 | -31.64% |
| Mar 31, 2022 | -25.16% |
| Dec 31, 2021 | -21.80% |
| Sep 30, 2021 | -23.85% |
| Jun 30, 2021 | -13.39% |